ABT vs FUNC · P/E 25, rev $44.33B vs P/E 10, rev $17.7M
Abbott Laboratories (ABT) versus First United Corporation (FUNC) — a side-by-side from cached financials, not a winner call.
Abbott Laboratories (ABT) is a medical devices company listed on NYSE.
First United Corporation (FUNC) is a banks - regional company listed on NASDAQ.
Latest reported ABT revenue for 2025-12-31 was $44.33B. Net income was $6.52B. Revenue was up 5.7% from 2024-12-31 to 2025-12-31. ABT currently screens at market cap $154.15B and trailing P/E 24.8.
Latest reported FUNC revenue for 2024-12-31 was $17.7M. Net income was $20.6M. Revenue was up 6.3% from 2023-12-31 to 2024-12-31. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
ABT currently screens at market cap $154.15B and trailing P/E 24.8. FUNC currently screens at market cap $263.4M and trailing P/E 10.5.
Not investment advice. Open the ABT and FUNC stock pages for the full models.
Not investment advice.